Potential therapeutic applications of plant toxin-ricin in cancer: challenges and advances
- PMID: 26349746
- DOI: 10.1007/s13277-015-4028-4
Potential therapeutic applications of plant toxin-ricin in cancer: challenges and advances
Abstract
Cancer is one of the most common devastating disease affecting millions of people per year worldwide. To fight against cancer, a number of natural plant compounds have been exploited by researchers to discover novel anti-cancer therapeutics with minimum or no side effects and plants have proved their usefulness in anti-cancer therapy in past few years. Ricin, a cytotoxic plant protein isolated from castor bean seeds, is a ribosome-inactivating protein which destroys the cells by inhibiting proteins synthesis. Ricin presents great potential as anti-cancer agent and exerts its anti-cancer activity by inducing apoptosis in cancer cells. In this review, we summarize the current information on anti-cancer properties of plant toxin ricin, its potential applications in cancer therapy, challenges associated with its use as therapeutic agent and the recent advances made to overcome these challenges. Nanotechnology could open the doors for quick development of ricin-based anti-cancer therapeutics. Conceivably, ricin may serve as a chemotherapeutic agent against cancer by utilizing nanocarriers for its targeted delivery to cancer cells.
Keywords: Drug delivery; Immunotoxins; Liposomes; Plant toxin; RTA; Ricin.
Similar articles
-
An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use.Cancer Res. 1991 Dec 1;51(23 Pt 1):6236-42. Cancer Res. 1991. PMID: 1718599
-
Ricin: An Ancient Story for a Timeless Plant Toxin.Toxins (Basel). 2019 Jun 6;11(6):324. doi: 10.3390/toxins11060324. Toxins (Basel). 2019. PMID: 31174319 Free PMC article. Review.
-
[Structure and properties of ricin – the toxic protein of Ricinus communis].Postepy Biochem. 2019 Jun 6;65(2):103-108. doi: 10.18388/pb.2019_249. Postepy Biochem. 2019. PMID: 31642648 Review. Polish.
-
Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7.Cancer Res. 1992 Mar 1;52(5):1314-21. Cancer Res. 1992. PMID: 1371092
-
The Search for Antidotes Against Ricin.Mini Rev Med Chem. 2024;24(12):1148-1161. doi: 10.2174/0113895575270509231121060105. Mini Rev Med Chem. 2024. PMID: 38350844 Review.
Cited by
-
Structural and Functional Investigation and Pharmacological Mechanism of Trichosanthin, a Type 1 Ribosome-Inactivating Protein.Toxins (Basel). 2018 Aug 20;10(8):335. doi: 10.3390/toxins10080335. Toxins (Basel). 2018. PMID: 30127254 Free PMC article. Review.
-
The mechanism of USP43 in the development of tumor: a literature review.Aging (Albany NY). 2024 Apr 8;16(7):6613-6626. doi: 10.18632/aging.205731. Epub 2024 Apr 8. Aging (Albany NY). 2024. PMID: 38613804 Free PMC article. Review.
-
Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview.Biomedicines. 2016 Jun 1;4(2):12. doi: 10.3390/biomedicines4020012. Biomedicines. 2016. PMID: 28536379 Free PMC article. Review.
-
DeBouganin Diabody Fusion Protein Overcomes Drug Resistance to ADCs Comprised of Anti-Microtubule Agents.Molecules. 2016 Dec 17;21(12):1741. doi: 10.3390/molecules21121741. Molecules. 2016. PMID: 27999336 Free PMC article.
-
An International Proficiency Test to Detect, Identify and Quantify Ricin in Complex Matrices.Toxins (Basel). 2015 Nov 26;7(12):4987-5010. doi: 10.3390/toxins7124859. Toxins (Basel). 2015. PMID: 26703726 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous